Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-24 @ 11:43 PM
NCT ID:
NCT04447651
Eligibility Criteria:
Inclusion Criteria:
* Performance status eligible for immune checkpoint blockade as determined by local physician
* Able to demonstrate histologically proven locally advanced or metastatic solid tumors (hematologic malignancies and lymphoma excluded)
* genomic testing demonstrating a spliceosome mutation (SF3B1, U2AF1 or SRSF2)
Exclusion Criteria:
* Local physician determines has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
* Local physician determines the patient has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the trial, interfere with the subject's participation for the full duration of the trial, or is not in the best interest of the subject to participate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04447651
Study Brief:
Protocol Section:
NCT04447651